Pharmagreen Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
For the nine months, net loss was USD 0.765082 million compared to USD 3.7 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0008 USD | 0.00% | 0.00% | +33.33% |
1st Jan change | Capi. | |
---|---|---|
+33.33% | 531K | |
+21.58% | 46.93B | |
+37.63% | 39.08B | |
-8.41% | 38.48B | |
+29.68% | 31.01B | |
-13.75% | 26.14B | |
+11.15% | 25.88B | |
+35.63% | 12.53B | |
-6.54% | 11.36B | |
-12.37% | 10.65B |